Company intelligence / Profile preview

BioDecade

Ownership: Private
Development stage: Other

Overview

BioDecade is a specialized consulting firm providing equity research and analytical services to investors in the biotechnology sector. The company’s expertise includes deep coverage of oligonucleotide therapeutics, cell therapy, and gene therapy companies. Dr. George S. Mack serves as managing director and leads much of the firm’s scientific analysis for institutional clients.

Modalities: Oligonucleotide therapiesCell therapiesGene therapies
Industry: Consulting

Beyond the preview

Go deeper on BioDecade.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDecade.

Explore the full profile